Processa Pharmaceuticals (Heatwurx Acquired Promet)

7380 Coca Cola Drive‪‬
Suite 106
Hanover
Maryland
21076‪‬
United States

Email: info@processapharma.com

Show jobs for this employer

About Processa Pharmaceuticals (Heatwurx Acquired Promet)

Processa Pharmaceuticals (OTCMKTS: PCSA) was formed in October 2017 as a result of an asset acquisition of Promet Therapeutics, LLC by Heatwurx, Inc (OTCMKTS: HUWX). Processa's mission is to develop products that can improve the survival and/or quality of life for patients who have a high unmet medical need. The company is headquartered in Hanover, Maryland.

YEAR FOUNDED:

October 2017

LEADERSHIP:

CEO: David Young

CDO: Sian Bigora

CSO: Helen Pentikis

CBO: Patrick Lin

CAO: Wendy Guy

CLINICAL TRIAL:

Please click here for clinical trial information.

7 articles with Processa Pharmaceuticals (Heatwurx Acquired Promet)